retatrutide weight loss retatrutide clinical trial Seeking Differentiation Through a Triple Mechanism" Eli Lilly's Again Proves Efficacy in Trials, Raising Question of Whether It Can Overcome Side-Effect Limits and Reshape the Market Triple hormone receptor agonist retatrutide

Methods A comprehensive literature review of PubMed, Embase, and Elsevier databases identified 17 relevant studies published between 2013 and 2024 that investigated the role of GLP-1 receptor agonists in bone metabolism, wound healing, and orthopedic surgery

Further processing falls entirely within the protocol of the customer's laboratory

Visceral versus subcutaneous fat While the trial did not break down visceral and subcutaneous fat reduction separately using imaging for all participants, the liver fat data serves as a strong proxy

GLP-1 receptor agonists offer a way to break the cycle

Role of GLP-1, GIP, and Glucagon GLP-1 agonists, like Retatrutide, work on the GLP-1 receptor to boost insulin and slow down glucagon

Data Availability All data are presented in this manuscript or supplemental figure